Antihypertensive drug therapy and risk of type 2 diabetes in an elderly cohort.
Published: 2004
Language: eng
Number of pages: 80
Description: This study sought to determine if the incidence of type 2 diabetes (DM2) differed amongst elderly users of four major antihypertensive drug classes. Population-based administrative databases were used to derive an incident cohort of non-diabetic antihypertensive drug users. In multivariable, adjusted, primary analysis (n = 76 176) using a Cox proportional hazards model, neither ACE inhibitor use (HR 0.96; 95% CI: 0.84--1.1) nor beta-blocker use (HR 0.86; 95% CI: 0.74--1.0) was associated with a statistically significant difference in DM2 incidence compared to the calcium channel blocker (CCB) control arm. In secondary analysis (n = 100 653), thiazide diuretics were added as a fourth study arm. Compared to CCB users, DM2 incidence was not significantly different between users of ACE inhibitors (HR 0.97; 95% CI: 0.83--1.1), beta-blockes (HR 0.84; 95% CI: 0.7--1.0), or thiazide diuretics (HR 1.0; 95% CI: 0.89--1.2). In conclusion, DM2 incidence did not differ amongst users of the major antihypertensive drug classes.
Notes: Adviser:  Andreas Laupacis.

Thesis (M.Sc.)--University of Toronto, 2004.

Electronic version licensed for access by U. of T. users.

Source: Masters Abstracts International, Volume: 42-06, page: 2179.

MICR copy on microfiche (1 microfiche).